Publications by authors named "Aaron Logan"

Claim this Profile
T
Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Elias Jabbour, Karamjeet S Sandhu, Paul Shaughnessy, Aaron C Logan, Mehrdad Abedi

Haematologica· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.
Kai Yu, Laura W Dillon, Jesse M Tettero, Gege Gui, Rasha W Al-Ali, Aaron Logan

medRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Timothy E O'Connor, Chenyu Lin, Gregory W Roloff, Amy Zhang, Katharine Miller, Aaron C Logan

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
North Atlantic right whale localization and source level estimation using two coherently beamformed linear arrays.
Ted A Abbot, Evan O Granite, Vincent E Premus, Eric D Illich, Aaron P Logan

J Acoust Soc Am· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.
Yannis K Valtis, Chenyu Lin, David Nemirovsky, Sean M Devlin, Kai Rejeski, Aaron C Logan

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology.
Alison W Loren, Marco Mielcarek, Javier Bolaños-Meade, Jonathan Brammer, Meredith Cowden, Aaron Logan

J Natl Compr Canc Netw· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML.
Bogdan Popescu, Matthew F Jones, Madison Piao, Elaine Tran, Andrew Koh, Aaron C Logan

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-βeta2.
Anju Wadhwa, Haley Johnson, Kondapa Naidu Bobba, Anil P Bidkar, Ellis Mayne, Aaron C Logan

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
Tamer Othman, Mimi M Lo, Charalambos B Andreadis, Lloyd E Damon, Timothy T Ferng, Aaron C Logan

Leuk Lymphoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bicistronic CAR T-cells Against CD70 & Active Integrin β2 Overcome Antigen Heterogeneity and Preserve Safety in Acute Myeloid Leukemia.
Amrik S Kang, Haley Johnson, Nicole Lei, Jeremiah Wong, Nabeel Razi, Aaron C Logan

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.
Ibrahim N Muhsen, Gregory W Roloff, Rawan Faramand, Tamer Othman, Yannis Valtis, Aaron C Logan

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503).
Brian A Jonas, Samantha C Fisch, Peter T Curtin, Gary J Schiller, Deepa Jeyakumar, Aaron C Logan

Leuk Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Belumosudil as Compared with Best Available Therapy for the Treatment of cGVHD in the US.
Kevin Hall, Aleksandr Lazaryan, Mark van Der Laan, Catherine J Lee, Aaron C Logan

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-βeta2.
Anju Wadhwa, Haley Johnson, Kondapa Naidu Bobba, Anil P Bidkar, Ellis Mayne, Aaron C Logan

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia.
Bogdan Popescu, Matthew F Jones, Madison Piao, Elaine Tran, Andrew Koh, Aaron C Logan

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
Bijal D Shah, Ryan D Cassaday, Jae H Park, Roch Houot, Aaron C Logan

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.
Caspian Oliai, Sunmin Park, Lloyd E Damon, Brian A Jonas, Deepa Jeyakumar, Aaron C Logan

Leuk Lymphoma· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts.
Nicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, Marina Konopleva, Jessica Leonard, Aaron C Logan

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.
Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, Chenyu Lin, Simone E Dekker, Aaron C Logan

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.
Claire Roddie, Karamjeet S Sandhu, Eleni Tholouli, Aaron C Logan, Paul Shaughnessy

N Engl J Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia.
Ibrahim Aldoss, Gail J Roboz, Renato Bassan, Nicolas Boissel, Daniel J DeAngelo, Aaron C Logan

Lancet Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab.
Elias J Jabbour, Hagop M Kantarjian, Nicola Goekbuget, Bijal D Shah, Sabina Chiaretti, Aaron C Logan

Blood Cancer J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss, Aaron Logan

J Natl Compr Canc Netw· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL.
Tamer Othman, Aaron C Logan, Lori Muffly, Jessica Leonard, Jae Park

J Natl Compr Canc Netw· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia.
Cheryl A C Peretz, Vanessa E Kennedy, Anushka Walia, Cyrille L Delley, Andrew Koh, Aaron C Logan

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis